Female Tubal Sterilization

The need for an easy, safe, effective, and inexpensive long-term method of preventing pregnancy has been sought for decades and is especially needed in the developing world. The safety and efficacy of female tubal sterilization have made it one of the mos

  • PDF / 6,789,250 Bytes
  • 427 Pages / 439.43 x 666.14 pts Page_size
  • 90 Downloads / 175 Views

DOWNLOAD

REPORT


Donna Shoupe Editor

The Handbook of Contraception Evidence Based Practice Recommendations and Rationales Third Edition

Current Clinical Practice Series Editor Tommy Koonce Family Medicine University of North Carolina at Chapel Hill Chapel Hill, USA

More information about this series at http://www.springer.com/series/7633

Donna Shoupe Editor

The Handbook of Contraception Evidence Based Practice Recommendations and Rationales Third Edition

Editor Donna Shoupe Keck School of Medicine University of Southern California Los Angeles CA USA

Current Clinical Practice ISBN 978-3-030-46390-8    ISBN 978-3-030-46391-5 (eBook) https://doi.org/10.1007/978-3-030-46391-5 © Springer Nature Switzerland AG 2020 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Humana imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland

This book is dedicated to my mentor Dr. Daniel Mishell, Jr. who led the field of contraception for over 40 years. For most of my training and early career, Dr. Mishell was editor of the leading journal Contraception. His major funding came from the World Health Organization, the Population Council, and the Ford Foundation. I worked for him for several years in the only clinical research and training center in human reproduction in the USA that was one of only 16 in the world. In the 1960s, Dr. Mishell performed the first immunoassays of human chorionic gonadotrophin in urine and serum, which was the breakthrough that lead to the first pregnancy tests in the USA not involving animals such as rabbits or frogs. He was the first to describe the midcycle luteinizing hormone peak in the middle of the menstrual cycle which eventually led to the home ovulation test that allows women who want to become pregnant to determine when they are most fertile.

He